Last reviewed · How we verify

NCT05666206

Efficacy of Fibrin Sealant in Hypospadias Surgery

Status unknown NA Last updated 13 February 2024
What this trial tests

NA trial testing fibrin sealant in hypospadias in Hypospadias in 200 participants. Status unknown.

Timeline
1 January 2022
Primary endpoint
1 November 2024
1 December 2024

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment200
Start date1 January 2022
Primary completion1 November 2024
Estimated completion1 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Adults 3 Months to 18, male only, with Hypospadias. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study was to evaluate if application of a fibrin sealant over the urethroplasty suture line for waterproofing instead of a dartos vascularized pedicled flap to reduce complications and improve the outcome in hypospadias repair.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Hypospadias

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05666206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing